Retinal fibers from ganglion cell neurons (circles) stream
through the optic nerve head on their way to brain.
Newswise, November 19, 2016 — What causes vision loss in
glaucoma? There are two common answers that at first may seem disparate: the
first is pressure, as in elevated ocular pressure, and the second is damage to
the optic nerve, which is the structure that sends visual information to the
brain. Both answers are correct.
Glaucoma involves sensitivity to ocular pressure (not just
elevated pressure) that is translated or transduced to stress
that degrades the optic nerve over time.
Current glaucoma therapies lower pressure using eye drops,
surgery, or both in order to reduce stress transduced to the optic nerve. This
approach is effective for many patients. But for those who continue to lose
vision, where should we turn for new clinical therapies?
One idea is to consider where ocular pressure exerts its
influence: the optic nerve head. This structure in the back of the eye defines
where nerve fibers leave the retina and enter the optic nerve.
The nerve head contains lateral structures that support these
fibers but also couple the nerve to the rest of the eye. In this way, pressure
in the front of the eye can cause stress to the optic nerve.
While we do not understand precisely how this stress is
conveyed, we do know that aging of the nerve head is likely to contribute to
its susceptibility. By addressing age-related factors, new research might
reveal therapies based on reducing the sensitivity of the nerve head to
pressure.
What about the optic nerve itself? Like the brain, the optic nerve and retina are part of the central nervous system. Once damaged beyond a certain point, these structures cannot heal.
For patients who have lost substantial optic nerve tissue in
glaucoma, the hope of regenerative medicine is to restore connectivity with the
brain by introducing new nerve fibers or inducing damaged ones to regrow.
Another area of promise that may be forthcoming leverages the
idea that increasing brain activity in some cases increases its resistance to
stress. Catalyst
for a Cure (CFC) research has demonstrated a "window of
structural persistence" in which connectivity between the optic nerve and
brain remains even when glaucoma affects visual function.
During this "window," optic nerve fibers attempt to
boost their electrical activity through natural self-repair mechanisms.
New research by CFC investigators shows
that enhanced activity can also help optic nerve fibers regenerate. Perhaps the
best approach to a new type of nerve-based glaucoma treatment would
combine optic nerve regenerative techniques with
those that promote intrinsic repair in the brain.
--
Article by David J. Calkins, PhD, the Director of Vanderbilt Vision Research Center, Vice-Chairman and Director for Research at The Vanderbilt Eye Institute, and the Denis M. O'Day Professor of Ophthalmology and Visual Sciences at The Vanderbilt University Medical Center.
Article by David J. Calkins, PhD, the Director of Vanderbilt Vision Research Center, Vice-Chairman and Director for Research at The Vanderbilt Eye Institute, and the Denis M. O'Day Professor of Ophthalmology and Visual Sciences at The Vanderbilt University Medical Center.
No comments:
Post a Comment